Initial Testing (Stage 1) of BAL101553, a Novel Tubulin Binding Agent, by the Pediatric Preclinical Testing Program

BAL101553 is a highly water soluble prodrug of BAL27862 that arrests tumor cell proliferation and induces cell death in cancer cells through disruption of the microtubule network. In vitro BAL27862 demonstrated potent activity, with the median relative IC(50) (rIC(50)) of 13.8 nM (range 5.4 to 25.2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Kolb, E. Anders, Gorlick, Richard, Keir, Stephen T., Maris, John M., Kang, Min H., Reynolds, C. Patrick, Lock, Richard B., Carol, Hernan, Wu, Jianrong, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405429/
https://ncbi.nlm.nih.gov/pubmed/25407467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados